From the three molecular subtypes, we screened UCP2, DKK1, MUC16, KRT6C, CAPN9, SFRP4 and other genes related to PAAD prognosis and constructed a clinical prognosis model. Here, UCP2 is linked to pancreatic adenocarcinoma.